Anti-Rad17 (phospho S645) antibody
Be the first to review this product! Submit a review
|
(5 Publications)
Rabbit Polyclonal RAD17 phospho S645 antibody. Suitable for IHC-P, WB and reacts with Mouse, Human samples. Cited in 5 publications. Immunogen corresponding to Synthetic Peptide within Human RAD17 pS645.
View Alternative Names
R24L, RAD17, Cell cycle checkpoint protein RAD17, hRad17, RF-C/activator 1 homolog
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Rad17 (phospho S645) antibody (AB3620)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human colon carcinoma tissue labelling Rad17 with ab3620 at 1/1000 dilution. Heat mediated antigen retrieval performed with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Rad17 (phospho S645) antibody (AB3620)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of mouse renal cell carcinoma tissue labelling Rad17 with ab3620 at 1/1000 dilution. Heat mediated antigen retrieval performed with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Supplier Data
Western blot - Anti-Rad17 (phospho S645) antibody (AB3620)
Lower panel : membrane was reblotted with goat anti-Rad17 antibody to examine total Rad17.
All lanes:
Western blot - Anti-Rad17 (phospho S645) antibody (ab3620) at 0.4 µg/mL
Lane 1:
HeLa whole cell lysate treated with Etoposide at 50 µg
Lane 2:
HeLa whole cell lysate mock-treated at 50 µg
Lane 3:
HEK293T whole cell lysate treated with Etoposide at 50 µg
Lane 4:
HEK293T whole cell lysate mock-treated at 50 µg
Predicted band size: 77 kDa
false
Exposure time: 30s
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Rad17 plays an important role in maintaining genome stability by activating cell cycle checkpoints. It belongs to the RFC-like complex which identifies DNA damage and initiates the DNA repair process. The complex binds to chromatin and helps recruit the 9-1-1 complex (Rad9-Rad1-Hus1) to sites of DNA damage. This action is important for the cell to halt the cell cycle and commence repair preventing mutations from being passed on during cell division.
Pathways
Rad17 functions in the DNA damage response pathway and is involved in the ATR-Chk1 pathway. Rad17 recruits ATR (ataxia-telangiectasia and Rad3-related protein) to stalled replication forks facilitating the phosphorylation and activation of Chk1 a checkpoint kinase. This signal allows cells to pause the replication process and repair DNA before continuing the cell cycle. Rad17 is closely related to proteins such as ATR and Chk1 through these pathways as they work together to maintain cellular integrity.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Cancer biology & therapy :1-9 PubMed32660328
2020
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 47:4068-4085 PubMed30799487
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cell cycle (Georgetown, Tex.) 11:1796-803 PubMed22453082
2012
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of 107:7491-6 PubMed20368419
2010
Applications
WB, ICC/IF
Species
Mouse, Mouse
Journal of virology 79:569-80 PubMed15596849
2004
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com